RNA Outsourcing Videos
-
Validation Of mRNA Concentration Determination
8/20/2023
mRNA-based therapeutics require comprehensive analytical testing to meet regulatory requirements. Optimize processes and ensure fast and reliable results as you bring your product to market.
-
Don't Forget These Important Points When Selecting An RNA CDMO
8/22/2024
Together, Omega’s Jeff Atkinson & Sail Biomedicines’ Jim Nolan share their perspectives on the health of the linear mRNA and circRNA outsourcing sector.
-
How Can Sponsors & CDMOs Collaborate On RNA Analytical/Process Development?
8/22/2024
Having worked on both the innovator and CDMO sides of the industry, Advancing RNA LIVE panelist Khaled Yamout outlines where he sees the greatest weaknesses in these critical sponsor-CDMO partnerships and offers guidance.
-
Addressing Industry Challenges In mRNA Product Commercialization
While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.
-
Customized mRNA Processing For Improved Therapy Development And Manufacturing
2/13/2025
Optimize mRNA development by learning key strategies for process refinement, critical component identification, and in-process analytics to enhance therapeutic production.
-
How "Successful" Are Our mRNA-LNP Outsourcing Partnerships Today?
2/10/2025
In this snippet, panelist Alex Aust (with the help of several live attendee commenters) tackles a particularly tricky question: Are our outsourcing partnerships producing high quality products today, and what are the most common root causes of batch failures?
-
ICH E6(R3): Practical Steps For Implementation
12/14/2023
Watch this presentation to equip stakeholders with actionable strategies and a comprehensive understanding of the evolving clinical trial management landscape in the context of ICH guidelines.
-
Key Benefits Of PCR-Based mRNA Manufacturing For Clinical Development
6/12/2023
To unlock the potential of your mRNA therapies and accelerate your development and manufacturing program, discover the benefits of a novel PCR-based mRNA drug substance manufacturing process.
-
A Deeper Dive On Mitigating Financial Risk Before Selecting A Vendor
1/23/2024
In part two of this webinar series, presenters focus on avoiding potential risks, such as unexpected budget changes and unplanned change orders, that could jeopardize the success of a clinical trial.
-
Intelligent Manufacturing Of mRNA Through The Power Of Process Analytical Technologies
3/10/2025
Learn how predictive models can monitor key CQAs, such as RNA concentration and nucleoside triphosphate consumption, and explore RBP and MIT’s vision for revolutionizing biomanufacturing.